Overview

Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The RAINIER Study)

Status:
Completed
Trial end date:
2018-09-20
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and effectiveness of OC-02 nasal spray compared to placebo on signs and symptoms of dry eye disease (DED).
Phase:
Phase 2
Details
Lead Sponsor:
Oyster Point Pharma, Inc.